Our services involve us harnessing the potential of experimental medicine approaches to run early, low cost, biomarker-inspired studies that can facilitate proof of mechanism and/or concept, to enable high-quality and timely decision making in CNS drug development.

Our Experimental Medicine models cover a variety of disease areas, and using a range of paradigms.
Our highly experienced team has extensive expertise in all aspects of CNS drug discovery and development, and we work closely in collaboration with leading academic centres to offer unique CNS research solutions.